4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-23-000010
Chief Financial Officer sold 1,004 shares at an average $12.55 ($12,603)
From the SEC's structured data for this filing
Trades in this filing
Greenstein Leonard M. · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-21 | Sale : show line 1 in the form | −326 | $12.89 | $4,202 | 32,463 | D |
| 2023-03-22 | Sale : show line 2 in the form | −332 | $12.64 | $4,196 | 32,131 | D |
| 2023-03-23 | Sale : show line 3 in the form | −346 | $12.15 | $4,204 | 31,785 | D |
| Open-market sales · 1,004 sh · avg $12.55 · $12,603 | ||||||
Loading xslF345X04/wf-form4_167961628683110.xml…